alias:: AC
parent:: [[Gallstone]], [[Cholecystitis]]
author:: [[Sira Pornsiriprasert]] 
Reviewer::
review-date::

- ## Pathophysiology
	- ### [[Acute Calculous Cholecystitis]]
	- {{embed ((6843fb92-e840-4942-b933-10bbdee8c89e))}}
	- ## [[Acute Acalculous Cholecystitis]]
		- {{embed ((684464f7-0f97-469f-a4a4-8db1d3504cb2))}}
- ## Diagnosis
  id:: 68450222-c8ca-48ed-a3fa-19aca4430ad3
  collapsed:: true
	- [[Acute Cholecystitis]] is diagnosed using the **[[Tokyo Guidelines 2018]]** [(Gallaher, 2022)]([[References/gallaherAcuteCholecystitisReview2022]]).
	- ### Criteria
		- **Suspected**: 1 local sign + 1 systemic sign
		- **Definite**: 1 local sign + 1 systemic sign + 1 image finding
	- ### Local Signs of Inflammation
		- [[Murphy Sign]] positive
		- [[RUQ]] mass, pain, or tenderness
	- ### Systemic Signs of Inflammation
		- [[Fever]]
		- Elevated [[CRP]]
		- Elevated [[WBC]] (WBC > 10,000) or depressed WBC (WBC < 4,000)
	- ### Imaging Findings Characteristic of Acute Cholecystitis
		- According to [(Yokoe, 2018)]([[References/yokoeTokyoGuidelines20182018]]), the accepted imaging findings of acute cholecystitis are:
			- **Thickening** of the gallbladder wall (≥4 mm)
			- **Enlargement** of the gallbladder (long axis ≥8 cm, short axis ≥4 cm)
			- **Gallstones** or retained debris
			- **Fluid accumulation** around the gallbladder
			- **Linear shadows** in the fatty tissue around the gallbladder
- ## Grading
  id:: 68450222-1a6f-4817-a98e-2b4d1a4b4952
	- Grading of acute cholecystitis follows the **[[Tokyo Guidelines]] 2018** [(Yokoe, 2018)]([[References/yokoeTokyoGuidelines20182018]]).
	- ### Grade III: Severe
	  id:: 68450222-656b-4a91-a8b6-a4909f1819ae
		- Any one of the following:
		  id:: 68450222-3b9c-4e9a-b9a4-a92e1ac79612
			- **Cardiovascular dysfunction**: [[Hypotension]] requiring treatment with [[Dopamine]] ≥5 μg/kg per min, or any dose of [[Norepinephrine]]
			  logseq.order-list-type:: number
			- **Neurological dysfunction**: decreased [[Level of Consciousness]]
			  logseq.order-list-type:: number
			- **Respiratory dysfunction**: PaO2/FiO2 ratio <300
			  logseq.order-list-type:: number
			- **Renal dysfunction**: [[Oliguria]], [[Creatinine]] >2.0 mg/dl
			  logseq.order-list-type:: number
			- **Hepatic dysfunction**: PT-INR >1.5
			  logseq.order-list-type:: number
			- **Hematological dysfunction**: [[Platelet]] count <100,000/mm3
			  logseq.order-list-type:: number
	- ### Grade II: Moderate
	  id:: 68450222-f784-4197-a93c-be9c065647f1
		- Any one of the following:
		  id:: 68450222-89f9-46a4-8b48-2c5c39a74d09
			- Elevated [[WBC]] count (>18,000/mm3)
			  logseq.order-list-type:: number
			- Palpable tender mass in the [[RUQ]]
			  logseq.order-list-type:: number
			- Duration of complaints >72 hr
			  logseq.order-list-type:: number
			- Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)
			  logseq.order-list-type:: number
	- ### Grade I: Mild
	  id:: 68450222-bd61-4473-b9ca-2e778bea6dcd
		- Acute cholecystitis that does not meet the Grade III or Grade II criteria or acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low-risk operative procedure
		  id:: 68450222-e20d-474e-8cff-00b5763147bc
- ## Management
	- ### Grade III: [[ATB]] + [[Cholecystostomy]]
	- ### Grade II: [[ATB]] + Urgent [[Cholecystectomy]]
	- ### Grade I: [[ATB]] + Urgent [[Cholecystectomy]]